- MedBot, a leading Chinese medical robotics company, received marketing approval for the dual-use surgical robot "SkyWalker" for hip and knee surgeries.
- With its increased precision, efficiency, and improved post-operation outcomes, MedBot is challenging the dominance of foreign brands in the field.
- The development has sparked interest on the potential future of robot-assisted surgeries.
by Fiscal Beat Staff | Sep 28, 2023